Concurrent Determination of Diltiazem, Lisinopril, Captopril, and Enalapril in Dosage Formulations and in Human Serum by Liquid Chromatographic Technique

References

• Delgado, J. N.; Remers, W. A. (eds.) Textbook of Organic Medicinal and Pharmaceutical Chemistry, 10th ed.; Lippincott-Raven: Philadelphia, PA, 1998; 603–607 pp.
   Google Scholar
• Sneader, W. Drug Prototypes and their Exploitation, Wiley: Chicester, UK, 1996.
   Google Scholar
• Sultana, N.; Saeed Arayne, M.; Shafi, N.; Siddiqui, F. A.; Hussain, A. Development of a RP-HPLC Method for the Simultaneous Analysis of Diltiazem and Statin: Application in Pharmaceuticals and Human Serum. Anal. Method. 2010, 2, 1571–1576.
   Web of Science ®Google Scholar
• Abraham, D. J. Burger’s Medicinal Chemistry and Drug Discovery, 6th ed.; Wiley: Hoboken, NJ, 2003; Chap 3, 15–17 pp.
   Google Scholar
• Gennaro, A. R. Remington: The Science and Practice of Pharmacy, 21st ed.; University of the Sciences in Philadelphia: Philadelphia, PA, 2005; 1364–1365 pp.
   Google Scholar
• Saeed Arayne, M.; Sultana, N.; Hashim Zuberi, M.; Siddiqui, F. A.; Haroon, U. Simultaneous Determination of Metformin, Captopril, Isinopril, and Enalapril by RP-HPLC: Its Applications in Dosage Formulations and in Human Serum. Med. Chem. Res. 2013, 22, 5717–5722. doi 10.1007/s00044-013-0501-z
   Web of Science ®Google Scholar
• Lancaster, S. G.; Todd, P. A. Lisinopril. A Preliminary Review of its Isinopril Amics and Pharmacokinetic Properties, and Therapeutic Use in Hypertension and Congestive Heart Failure. Drugs 1988, 35 (6), 646.
   PubMed Web of Science ®Google Scholar
• Campbell, R. W. F. Coadministration of Calcium Antagonists and ACE Inhibitors-Is a Skeptic Convinced?: A Personal View. Cardiovasc. Drugs Ther. 1995, 9 (3), 525–529.
   PubMed Web of Science ®Google Scholar
• Ruschitzka, F. T.; Noll, G.; Lüscher, T. F. Combination of ACE Inhibitors and Calcium Antagonists: A Logical Approach. J. Cardiovasc. Pharmacol. 1998, 31 (Suppl 2), S5–S16.
   PubMedGoogle Scholar
• Striessnig, J.; Grabner, M.; Mettedorfer, J.; Hering, S.; Sinnegger, M. J.; Glossmann, H. Structural Basis of Drug Binding to L Ca2+ Channels. TIPS 1998, 19, 108–115.
   PubMed Web of Science ®Google Scholar
• Chobanian, A. V.; Bakris, G. L.; Black, H. R.; Cushman, W. C.; Green, L. A.; Izzo Jr, J. L.; Jones, D. W.; Materson, B. J.; Oparil, S.; Wright Jr, J. T.; Roccella, E. J. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003, 42, 1206.
   PubMed Web of Science ®Google Scholar
• Matsuzaki, K.; Mukai, M.; Sumimoto, T.; Murakami, E. Effects of ACE Inhibitors Versus Calcium Antagonists on Left Ventricular Morphology and Function in Patients with Essential Hypertension. Hypertens. Res. 1997, 20 (1), 7–10.
   PubMedGoogle Scholar
• Peck, P. Calcium Channel Blocker and ACE Inhibitor Combo Shows Benefit for Hypertension (Orlando); Medscape Today, Medical News. March 14, 2005.
   Google Scholar
• Curtis, T. Drug Interactions of Medications Commonly Used in Diabetes. Diabetes Spectrum 2006, 19 (4), 202–211.
   Google Scholar
• Shigehiro, K.; Ryuzo, K.; Yasuhiko, I.; Ikuo, S.; Kizuku, K. Hypertensive Diabetics, Co-Administration of a Calcium Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor Achieved a Target Blood Pressure of <130/80 mmHg: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes (ATTEST) Study. Hypertens. Res. 2008, 31, 1499–1508.
   PubMed Web of Science ®Google Scholar
• He, Y. L.; Ligueros-Saylan, M.; Sunkara, G.; Sabo, R.; Zhao, C.; Wang, Y.; Campestrini, J.; Pommier, F.; Dole, K.; Marion, A.; Dole, W. P.; Howard, D. Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects. J. Clin. Pharmacol. 2008, 48 (1), 85–95.
   PubMed Web of Science ®Google Scholar
• Stergiou, G. S.; Makris, T.; Papavasiliou, M.; Efstathiou, S.; Manolis, A. Comparison of Antihypertensive Effects of an Angiotensin-converting Enzyme Inhibitor, a Calcium Antagonist and a Diuretic in Patients with Hypertension Not Controlled by Angiotensin Receptor Blocker Monotherapy. J. Hypertens. 2005, 23 (4), 883–889.
   PubMed Web of Science ®Google Scholar
• Raicu, M.; Pojoga, L.; Simionescu, N.; Simionescu, M. The Effect of ACE Inhibitors on Atheroma Formation is Potentiated by Association with a Calcium Channel Blocker. A Biochemical and Ultrastructural Study. J. Submicrosc. Cytol. Pathol. 1997, 29 (3), 317–328.
   PubMed Web of Science ®Google Scholar
• Fraňová, S.; Nosál’ová, G.; Antošová, M.; Nosáľ, S. Enalapril and Diltiazem Co-Administration and Respiratory Side Effects of Enalapril. Physiol. Res. 2005, 54, 515–520.
   PubMed Web of Science ®Google Scholar
• G:\Website\Drug Classes\Drug Classes Final Copy. Calcium Channel Blockers.doc 3. CALCIUM CHANNEL BLOCKERS (CCBs). Drug Classes. British Hypertension Society, Dec. 2008.
   Google Scholar
• Lena, K.; Elisabeth, L. Ø.; Mimi, S. O.; Mette, K.; Elsa, L.; Asbjørg, S. C. Simultaneous Determination of 6 Beta-blockers, 3 Calcium-channel Antagonists, 4 Angiotensin-II Antagonists and 1 Antiarrhytmic Drug in Post-mortem Whole Blood by Automated Solid Phase Extraction and Liquid Chromatography Mass Spectrometry. Method Development and Robustness Testing by Experimental Design. J. Chromatogr. B 2007, 850, 147.
   PubMed Web of Science ®Google Scholar
• Mustafa, Ç.; Mustafa, S. K.; Sacide, A.; Selma, Ş. Validated HPLC Method Development: The Simultaneous Analysis of Amlodipine and Valsartan in Samples for Liver Perfusion Studies. Hacettepe University Journal of the Faculty of Pharmacy 2008, 28 (1), 15–30.
   Google Scholar
• Sivakumar, T.; Venkatesan, P.; Manavalan, R.; Valliappan, K. Development of a HPLC Method for the Simultaneous Determination of Losartan Potassium and Atenolol in Tablets. Indian J. Pharm. Sci. 2007, 69 (1), 154–157.
   Google Scholar
• Manna, L.; Valvo, L.; Alirnonti, S. A. Liquid Chromatographic Ion-pairing Method for Simultaneous Determination of Benazepril Hydrochloride, Fosinopril Sodium, Ramipril and Hydrochlorothiazide in Pharmaceutical Formulations. Chromatographia. 2001, 53, S-271–S275.
   Web of Science ®Google Scholar
• Raghu Naidu, K.; Udhav, N. K.; Murlidhar, S. S. Stability Indicating RP-HPLC Method for Simultaneous Determination of Amlodipine and Benazepril Hydrochloride from Their Combination Drug Product. J. Pharm. Biomed. Anal. 2005, 39 (1–2), 147–155.
   PubMed Web of Science ®Google Scholar
• Bhushan, R.; Gupta, D.; Shravan, K. S. Liquid Chromatographic Separation and UV Determination of Certain Antihypertensive Agents. Biomed. Chromatogr. 2005, 20 (2), 217–224.
   Web of Science ®Google Scholar
• Ivanović, D.; Medenica, M.; Jančić, B.; Knežević, N.; Malenović, A.; Milić, J. Validation of an Analytical Procedure for Simultaneous Determination of Hydrochlorothiazide, Isinopril, and Their Impurities. Acta Chromatogr. 2007, 18, 143–156.
   Web of Science ®Google Scholar
• Girija, B. B.; Chatpalliwar, V. A.; Patil, D. D.; Surana, S. J. Validated HPTLC Method for Simultaneous Determination of Quinapril Hydrochloride and Hydrochlorothiazide in a Tablet Dosage Form. Indian J. Pharm. Sci. 2008, 70 (4), 529–531.
   PubMed Web of Science ®Google Scholar
• Wankhede, S. B.; Tajne, M. R.; Gupta, K. R.; Wadodkar, S. G. RP-HPLC Method for Simultaneous Estimation of Telmisartan and Hydrochlorothiazide in Tablet Dosage Form. Indian J. Pharm. Sci. 2007, 69 (2), 298–300.
   Google Scholar
• Siddiqui, F. A.; Sher, N.; Shafi, N.; Bahadur, S. S. Concurrent determination of Metformin and some ACE inhibitors: Its application to Pharmacokinetics. Arab. J. Chem. 2013, doi:10.1016/j.arabjc.2013.11.035
   Google Scholar
• Sultana, N.; Saeed Arayne, M.; Shafi, N.; Siddiqui, F. A.; Hussain, A. Development and Validation of New Assay Method for the Simultaneous Analysis of Diltiazem, Metformin, Pioglitazone and Rosiglitazone by RP-HPLC and Its Applications in Pharmaceuticals and Human Serum. J. Chromatogr. Sci. 2011, 49 (10), 774–779.
   PubMed Web of Science ®Google Scholar
• Sultana, N.; Arayne, M. S.; Shafi, N.; Siddiqui, F. A. Simultaneous RP-LC Analysis of Diltiazem and Non-Steroidal Anti-Inflammatory Drugs in Pharmaceutical Formulations and Human Serum. Chromatographia 2010, 71, 71–77.
   Web of Science ®Google Scholar
• Vessman, J. Selectivity or Specificity? Validation of Analytical Methods from the Perspective of an Analytical Chemist in the Pharmaceutical Industry. J. Pharm. Biomed. Anal. 1996, 14, 867–869.
   PubMed Web of Science ®Google Scholar
• Mirza, A. Z.; Siddiqui, F. A. New, Simple and Validated UV-spectrophotometric Methods for the Estimation of Pyridoxine Hydrochloride in Bulk and Formulation. Bulg. Chem. Comm. 2015, 47 (1), 131–134.
   Google Scholar
• Sher, N.; Fatima, N.; Parveen, S.; Sidiqui, F. A.; Sial, A. W. Pregabalin and Tranexamic Acid Evaluation by Two Simple and Sensitive Spectrophotometric Methods. Int. J. Anal. Chem. 2015, 2015 (241412), 7 pages. http://dx.doi.org/10.1155/2015/241412
   Google Scholar
• Sher, N.; Siddiqui, F. A.; Fatima, N.; Perveen, S.; Shafi, N. New Method Development for Hydroxyzine Determination: Application in Stability Studies, Pharmaceutical Formulations and Humane Serum. J. Liq. Chromatogr. Rel. Technol. 2015, 38, 911–918.
   Web of Science ®Google Scholar
• Siddiqui, F. A.; Sher, N.; Shafi, N.; Sial, A. W.; Ahmed, M.; Mehjebeen; Naseem, H. Development of New Method for Simultaneous Analysis of Piracetam and Levetiracetam in Pharmaceuticals and Biological Fluids: Application in Stability Studies. BioMed Res. Int. 2014, 2014 (758283), 8 pages. http://dx.doi.org/10.1155/2014/758283
   Google Scholar
• Sher, N.; Siddiqui, F. A.; Hasan, N.; Shafi, N.; Zubair, A.; Mirza, A. Z. Simultaneous Determination of Antihistamin Antallergic Drugs, Cetirizine Hydrochloride, Domperidone, Chlorphiniramine Maleate, Loratidine, Meclizine and Buclizine in Pharmaceutical Formulations, Human Serum and Pharmacokinetics Application. Anal. Methods 2014, 6, 2704–2714. doi:10.1039/C3AY41698D.
   Web of Science ®Google Scholar
• ICH Guideline. Q2B: Validation of Analytical Procedures: Methodology; ICH IFPMA: Geneva, 2003.
   Google Scholar
• Krull, I.; Swartz, M. Validation Viewpoint, Introduction: National and International Guidelines. LC-GC. 1997, 15 (6), 534–539.
   Google Scholar
• Plackett, R. L.; Burman, J. P. The Design of Optimum Multifactorial Experiments. Biometrika 1943–1946, 33, 305–325.
   Google Scholar
• ASTM E (1169–89) American Society for Testing and Materials. Standard Guide for Conducting Ruggedness Tests (Plackett-Burman Design). ASTM International: West Conshohocken, PA, 1996.
   Google Scholar
• Siddiqui, F. A.; Sher, N.; Shamshad, H.; Shafi, N. Analysis of Metformin, Glimepiride and Pioglitazone in Human Serum and Its Application to Pharmacokinetic. Anal. Methods 2013, 5, 5096–5104. doi:10.1039/c3ay40884a.
   Web of Science ®Google Scholar
• Hasan, N.; Chaiharn, M.; Khan, S.; Khalid, H.; Sher, N.; Siddiqui, F. A.; Siddiqui, M. Z. Dual Wavelength RP-HPLC Method for Simultaneous Determination of Two Antispasmodic Drugs: An Application in Pharmaceutical and Human Serum. J. Anal. Method. Chem. 2013, 2013 (297285), 7 pages http://dx.doi.org/10.1155/2013/297285
   Google Scholar